• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旨在减少癌症化疗期间发热伴中性粒细胞减少症(FN)患者抗生素使用时间(TTA)的干预措施:系统评价。

Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review.

机构信息

Division of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 15, CH-3010, Bern, Switzerland.

Centre for Reviews and Dissemination, University of York, York, UK.

出版信息

Support Care Cancer. 2020 May;28(5):2369-2380. doi: 10.1007/s00520-019-05056-w. Epub 2019 Sep 5.

DOI:10.1007/s00520-019-05056-w
PMID:31486984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7083808/
Abstract

PURPOSE

Multiple interventions have been developed aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia (FN) following chemotherapy for cancer. We evaluated their effect to reduce TTA and their impact on important clinical outcomes in a systematic review.

METHODS

The search covered seven databases. Biases and quality of studies were assessed with the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool. Interventions could be implemented in any setting and performed by any person included in the FN management. Absolute change of TTA was the primary outcome. Registration: PROSPERO (CRD42018092948).

RESULTS

Six thousand two hundred ninety-six titles and abstracts were screened, 177 studies were retrieved and 30 studies were included. Risk of bias was moderate to serious in 28 studies and low in two studies. All but one study reported a reduction of TTA after the intervention. Various types of interventions were implemented; they most commonly aimed at professionals. Most of the studies made more than one single intervention.

CONCLUSION

This review may help centers to identify their specific sources of delay and barriers to change and to define what intervention may be the best to apply. This review supports the assertion that TTA can be considered a measure of quality of care, emphasizes the importance of education and training, and describes the very different interventions which have effectively reduced TTA.

摘要

目的

为了降低癌症化疗后发热伴中性粒细胞减少症(FN)患者的抗生素治疗时间(TTA),已经开发了多种干预措施。我们通过系统评价评估了这些措施在降低 TTA 方面的效果及其对重要临床结局的影响。

方法

检索了七个数据库。使用非随机干预研究的偏倚风险(ROBINS-I)工具评估了研究的偏倚和质量。干预措施可以在任何环境中实施,并由参与 FN 管理的任何人执行。TTA 的绝对变化是主要结局。注册:PROSPERO(CRD42018092948)。

结果

筛选了 6296 篇标题和摘要,检索到 177 篇研究,纳入了 30 篇研究。28 项研究的偏倚风险为中度至严重,2 项研究的偏倚风险为低。干预后,除了一项研究外,所有研究均报告了 TTA 的降低。实施了各种类型的干预措施;它们最常针对专业人员。大多数研究进行了不止一项单一的干预措施。

结论

本综述可能有助于中心确定其特定的延迟来源和变革障碍,并确定可能应用的最佳干预措施。本综述支持 TTA 可被视为护理质量的衡量标准的观点,强调了教育和培训的重要性,并描述了可有效降低 TTA 的各种干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a98/7083808/27024512300d/520_2019_5056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a98/7083808/3d488cb87c7a/520_2019_5056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a98/7083808/27024512300d/520_2019_5056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a98/7083808/3d488cb87c7a/520_2019_5056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a98/7083808/27024512300d/520_2019_5056_Fig2_HTML.jpg

相似文献

1
Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review.旨在减少癌症化疗期间发热伴中性粒细胞减少症(FN)患者抗生素使用时间(TTA)的干预措施:系统评价。
Support Care Cancer. 2020 May;28(5):2369-2380. doi: 10.1007/s00520-019-05056-w. Epub 2019 Sep 5.
2
Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA.发热伴中性粒细胞减少的癌症化疗患者使用抗生素的时间(TTA)的系统评价方案,以及旨在缩短 TTA 的干预措施。
Syst Rev. 2019 Apr 3;8(1):82. doi: 10.1186/s13643-019-1006-8.
3
Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.癌症化疗期间发热伴中性粒细胞减少症患者使用抗生素的时间与临床结局的关系:系统评价。
Support Care Cancer. 2020 Mar;28(3):1369-1383. doi: 10.1007/s00520-019-04961-4. Epub 2019 Jul 1.
4
Implementation of a Nursing Based Order Set: Improved Antibiotic Administration Times for Pediatric ED Patients with Therapy-Induced Neutropenia and Fever.实施基于护理的医嘱集:改善因治疗导致中性粒细胞减少和发热的儿科 ED 患者的抗生素给药时间。
J Pediatr Nurs. 2019 May-Jun;46:78-82. doi: 10.1016/j.pedn.2019.02.028. Epub 2019 Mar 8.
5
Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs.在不到60分钟内接受抗生素治疗发热和中性粒细胞减少症的儿科患者对重症监护的需求减少。
Pediatr Blood Cancer. 2015 May;62(5):807-15. doi: 10.1002/pbc.25435. Epub 2015 Feb 7.
6
Assessment of Fever Advisory Cards (FACs) as an Initiative to Improve Febrile Neutropenia Management in a Regional Cancer Center Emergency Department.评估发热咨询卡(FACs)作为区域癌症中心急诊科改善发热性中性粒细胞减少症管理的一项举措。
J Oncol Pract. 2016 Sep;12(9):e858-63. doi: 10.1200/JOP.2015.009183. Epub 2016 Aug 2.
7
[Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)].[抗生素使用时机(TTA)——德国儿童和青少年发热与中性粒细胞减少工作组(DGPI/GPOH)的重新评估]
Klin Padiatr. 2023 Nov;235(6):331-341. doi: 10.1055/a-2135-4210. Epub 2023 Sep 26.
8
Time to antibiotics is unrelated to outcome in pediatric patients with fever in neutropenia presenting without severe disease during chemotherapy for cancer.中性粒细胞减少症的癌症化疗患儿出现发热且无严重疾病时,抗生素使用时间与临床结局无关。
Sci Rep. 2022 Aug 18;12(1):14028. doi: 10.1038/s41598-022-18168-x.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.低菌饮食与对照饮食预防化疗导致中性粒细胞减少发作的癌症患者感染的比较
Cochrane Database Syst Rev. 2016 Apr 24;4(4):CD006247. doi: 10.1002/14651858.CD006247.pub3.

引用本文的文献

1
Severe outcomes and risk factors of non-neutropenic fever episodes in hospitalized children with cancer in Kenya.肯尼亚住院癌症患儿非中性粒细胞减少性发热发作的严重后果及危险因素
Front Oncol. 2025 May 12;15:1575714. doi: 10.3389/fonc.2025.1575714. eCollection 2025.
2
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes.抗生素使用时间对儿童发热性中性粒细胞减少症临床结局的影响:1685例病例的目标试验模拟
Lancet Reg Health West Pac. 2024 Nov 2;53:101226. doi: 10.1016/j.lanwpc.2024.101226. eCollection 2024 Dec.
3
Overcoming challenges to reduce time to antibiotic therapy in febrile neutropenic children: insights from a Mexican center.

本文引用的文献

1
Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.癌症化疗期间发热伴中性粒细胞减少症患者使用抗生素的时间与临床结局的关系:系统评价。
Support Care Cancer. 2020 Mar;28(3):1369-1383. doi: 10.1007/s00520-019-04961-4. Epub 2019 Jul 1.
2
Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA.发热伴中性粒细胞减少的癌症化疗患者使用抗生素的时间(TTA)的系统评价方案,以及旨在缩短 TTA 的干预措施。
Syst Rev. 2019 Apr 3;8(1):82. doi: 10.1186/s13643-019-1006-8.
3
克服挑战以缩短发热性中性粒细胞减少儿童的抗生素治疗时间:来自墨西哥一家中心的见解
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S193-S201. doi: 10.1016/j.htct.2024.04.123. Epub 2024 Aug 18.
4
Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia.癌症合并发热性中性粒细胞减少症患儿抗生素给药时间的影响。
JCO Oncol Pract. 2024 Feb;20(2):228-238. doi: 10.1200/OP.23.00583. Epub 2023 Dec 21.
5
Time to antibiotics is unrelated to outcome in pediatric patients with fever in neutropenia presenting without severe disease during chemotherapy for cancer.中性粒细胞减少症的癌症化疗患儿出现发热且无严重疾病时,抗生素使用时间与临床结局无关。
Sci Rep. 2022 Aug 18;12(1):14028. doi: 10.1038/s41598-022-18168-x.
6
Time to antibiotic administration in children with febrile neutropenia: Report from a low middle-income country.发热性中性粒细胞减少症患儿应用抗生素的时间:来自中低收入国家的报告。
Indian J Med Res. 2021 Apr;154(4):615-622. doi: 10.4103/ijmr.IJMR_2483_19.
7
A modified emergency severity index level is associated with outcomes in cancer patients with COVID-19.改良版紧急严重指数与 COVID-19 癌症患者的结局相关。
Am J Emerg Med. 2022 Apr;54:111-116. doi: 10.1016/j.ajem.2022.02.002. Epub 2022 Feb 5.
8
The Golden Hour: Sustainability and Clinical Outcomes of Adequate Time to Antibiotic Administration in Children with Cancer and Febrile Neutropenia in Northwestern Mexico.黄金时间:墨西哥西北部癌症儿童伴发热性中性粒细胞减少症患者给予抗生素的充分时间与可持续性及临床结局的关系。
JCO Glob Oncol. 2021 May;7:659-670. doi: 10.1200/GO.20.00578.
9
Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children.优化儿童发热性中性粒细胞减少症治疗中的抗菌药物选择与疗程
Infect Drug Resist. 2021 Mar 30;14:1283-1293. doi: 10.2147/IDR.S238567. eCollection 2021.
Implementation of a Nursing Based Order Set: Improved Antibiotic Administration Times for Pediatric ED Patients with Therapy-Induced Neutropenia and Fever.
实施基于护理的医嘱集:改善因治疗导致中性粒细胞减少和发热的儿科 ED 患者的抗生素给药时间。
J Pediatr Nurs. 2019 May-Jun;46:78-82. doi: 10.1016/j.pedn.2019.02.028. Epub 2019 Mar 8.
4
Quality Initiative to Improve time to Antibiotics for Febrile Pediatric Patients with Potential Neutropenia.提高潜在中性粒细胞减少的发热儿科患者使用抗生素及时性的质量改进计划。
Pediatr Qual Saf. 2018 Aug 9;3(4):e095. doi: 10.1097/pq9.0000000000000095. eCollection 2018 Jul-Aug.
5
An Initiative to Decrease Time to Antibiotics for Patients With Fever and Neutropenia.一项旨在缩短发热性中性粒细胞减少症患者使用抗生素时间的倡议。
Am J Med Qual. 2019 Mar/Apr;34(2):158-164. doi: 10.1177/1062860618792305. Epub 2018 Aug 6.
6
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.成人恶性肿瘤患者发热与中性粒细胞减少的门诊管理:美国临床肿瘤学会与感染病学会临床实践指南更新
J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20.
7
Using Process Improvement Tools to Improve the Care of Patients With Neutropenic Fever in the Emergency Room.使用流程改进工具改善急诊中性粒细胞减少症发热患者的护理。
J Oncol Pract. 2018 Jan;14(1):e73-e81. doi: 10.1200/JOP.2017.026054.
8
Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections: An Emergency Department-Based Quality Improvement Intervention.缩短疑似感染的儿科肿瘤患者使用抗生素的时间:一项基于急诊科的质量改进干预措施。
Pediatr Emerg Care. 2018 Jan;34(1):47-52. doi: 10.1097/PEC.0000000000001367.
9
Implementation of a Pathway for the Treatment of Fever and Neutropenia in Pediatric Patients With Cancer.癌症患儿发热和中性粒细胞减少症治疗路径的实施
J Pediatr Oncol Nurs. 2017 Sep/Oct;34(5):315-321. doi: 10.1177/1043454217691231. Epub 2017 Mar 1.
10
Successful emergency department interventions that reduce time to antibiotics in febrile pediatric cancer patients.在发热的儿科癌症患者中,可减少抗生素使用时间的成功急诊科干预措施。
BMJ Qual Improv Rep. 2017 Mar 7;6(1). doi: 10.1136/bmjquality.u212406.w4933. eCollection 2017.